Eli Lilly (NYSE:LLY) Surges 5% Following Breakthrough BRAVE-AA-PEDS Study Results
Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational ...
STAT1d
Lilly CEO got a big payday (and an Olympics treat)
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
CNN on MSN15d
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs ... Increasing US manufacturing of pharmaceuticals emerged as a more urgent priority during the Covid-19 pandemic as supply ...
Becker's Hospital Review19h
10 drugs poised to be best-sellers in 2026
The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.
Eli Lilly takes aim at weight-loss drug copies with new ad campaign
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
Northcountrypublicradio.org13d
It's the 5th anniversary of the COVID pandemic and we want to hear your experiences
It's been 5 years since the World Health Organization declared COVID-19 a global pandemic ... freedom of expression may ...
Indianapolis Business Journal8d
Zepbound raises profile of Lilly’s direct-to-consumer sales initiative
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
Study: COVID-19 hospital patients face greater risk of death for 2 or more years afterward
People hospitalized for a severe bout of COVID-19 are far from in the clear after they've recovered enough to return home, a ...